Additional drugs to have site-of-care requirement for most commercial members, starting June 1
Starting June 1, 2026, Blue Cross Blue Shield of Michigan and Blue Care Network are adding site-of-care requirements for 12 specialty drugs already requiring prior authorization. Providers must now specify and justify the administration site when requesting prior authorization, with automatic approval for office, ambulatory infusion center, or home settings, but additional documentation required for hospital outpatient settings.